India bans all exports of hydroxychloroquine, a malaria drug that President Donald Trump has touted as a “game changer” within the battle against COVID-19.
Exports of the drug and its formulations are prohibited “with no exceptions” and with quick impact, India’s Directorate Common of Overseas Commerce mentioned in an April four order on its web site. The commerce regulator had final month restricted abroad shipments of the drug, permitting solely restricted exceptions reminiscent of on humanitarian grounds and for assembly prior commitments.
At a press convention on Saturday, Trump mentioned he spoke to Indian Prime Minister Narendra Modi and appealed for the discharge of shipments the U.S. has already ordered. India is giving his request “critical consideration,” he mentioned.
There’s no conclusive scientific proof that hydroxychloroquine can deal with the infection from the novel pathogen.
The ban displays India’s rising concern over the speedy spread of the coronavirus, with dangers of group spread rising within the nation of 1.Three billion people.
India has recorded 3,374 positive cases up to now and has lost 77 lives, in accordance with the federal health ministry. The nation has struggled to maintain people indoors throughout a three-week lockdown that began March 25, elevating fears of accelerating spread.